Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19

Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19
复制标题

DOI：
10.1136/heartjnl-2020-317355
复制
发表时间：
2020-09-01
期刊：
HEART
影响因子：
5.7
通讯作者：
Cappelletti, Alberto Maria
Cappelletti, Alberto Maria
中科院分区：
医学1区
文献类型：
--
作者：
Pagnesi, Matteo;Baldetti, Luca;Cappelletti, Alberto Maria

文献摘要

被引文献

相似文献

目的探讨非重症监护病房(ICU)合并冠状病毒病(新冠肺炎)患者的肺动脉高压(PH)和右心功能不全(RVD)的发生率、特点及预后价值。排除声窗差的患者(n=11)。比较有无PH(估计的肺动脉收缩压35 mm Hg)和无RVD(三尖瓣环平面收缩期离散度)患者的临床、影像、实验室和TTE结果。
Objective To assess the prevalence, characteristics and prognostic value of pulmonary hypertension (PH) and right ventricular dysfunction (RVD) in hospitalised, non-intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19).Methods This single-centre, observational, cross-sectional study included 211 patients with COVID-19 admitted to non-ICU departments who underwent a single transthoracic echocardiography (TTE). Patients with poor acoustic window (n=11) were excluded. Clinical, imaging, laboratory and TTE findings were compared in patients with versus without PH (estimated systolic pulmonary artery pressure >35 mm Hg) and with versus without RVD (tricuspid annular plane systolic excursion